サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：カルシウム拮抗薬市場：薬剤クラス別、用途別、流通経路別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1339877

カルシウム拮抗薬市場：薬剤クラス別、用途別、流通経路別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Calcium Channel Blockers Market with COVID-19 Impact Analysis, By Drug Class, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 308 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
カルシウム拮抗薬市場：薬剤クラス別、用途別、流通経路別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年08月01日
発行: AnalystView Market Insights
ページ情報: 英文 308 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

カルシウム拮抗薬の市場規模は2022年に140億510万米ドルで、2023年から2030年にかけてCAGR 6.1%で拡大

カルシウム拮抗薬市場-市場力学：

  • 心血管疾患の有病率の増加、不安障害や双極性障害の患者への支援の高まりが、予測期間の成長を促進すると予測されます。
  • 人々のライフスタイルの変化は、心血管疾患の有病率の増加をもたらし、カルシウム拮抗薬市場の成長を促進する可能性が高いです。これらの疾患は心臓や血管に影響を与え、心不全や脳卒中のリスクを低下させるため、カルシウム拮抗薬が使用されます。さらに、心臓病に関連する主な原因は、しばしば血圧上昇と呼ばれる高血圧です。カルシウム拮抗薬が高血圧症に有効であることはよく知られています。そのため、心血管疾患の管理を改善するために、カルシウム拮抗薬市場の需要は着実に伸びています。しかし、頭痛、便秘、浮腫などのカルシウム拮抗薬に関する副作用が、カルシウム拮抗薬市場の世界の需要の妨げになると予想されています。さらに、カルシウム拮抗薬は、心臓に問題のない少数の人々にとって有利である可能性があります。これに関連して、カルシウム拮抗薬は気分安定薬として作用し、不安障害や双極性障害に苦しむ人々を支援する可能性があるとの指摘もあります。特に後者については、従来の気分安定薬や抗精神病薬に比べ、カルシウム拮抗薬の中には妊婦に投与しても安全なものがあるため、現在調査中です。したがって、このような要因はカルシウム拮抗薬市場を成長させる機会となります。

カルシウム拮抗薬市場-セグメンテーション分析：

  • カルシウム拮抗薬の世界市場は、薬剤クラス別、用途別、流通チャネル別、地域別に区分されます。
  • 薬剤クラス別では、ジヒドロピリジン、フェニルアルキルアミン、ベンゾチゼピンの3つに分類されます。ジヒドロピリジンセグメンテーションは、最大の収益シェアを有すると思われます。このセグメントは、研究開発活動の増加と製薬業界の拡大により期待されています。さらに、この薬剤は血管選択性が高く、動脈圧や血管抵抗をコントロールする能力があるため、治療薬として広く好まれています。ジヒドロピリジン系薬剤には、フェロジピン、アムロジピン、ニトレンジピン、ニモジピンなどがあります。
  • 市場は用途によって狭心症、高血圧、肥大型心筋症、不整脈、その他の4つに分類されます。最大の市場シェアを占めるのは高血圧セグメントです。高血圧セグメントは、心臓、脳、腎臓の問題のリスクを高める。このため、高血圧の管理に使用される薬剤の需要が増加するとみられます。
  • 同市場は、流通チャネルによってオンライン薬局、病院薬局、小売薬局の3つに分類されます。予測期間中、市場を独占するのは小売薬局セグメントです。不健康な生活パターンが肥満や心血管疾患の増加をもたらしています。そのため、血圧を維持するための薬剤が定期的に処方されています。さらに、先天性心疾患、心不全、高血圧症、心臓発作などの心血管疾患の症例が増加していることが、市場における豊富かつ大量消費の増加により、小売薬の拡大に拍車をかけています。

カルシウム拮抗薬市場-地理的洞察：

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

カルシウム拮抗薬市場-競合情勢：

地元企業と世界企業の存在により、カルシウム拮抗薬市場は適度な競争状態にあります。主要企業は、提携、製品上市、買収など数多くの成長戦略に注力しており、カルシウム拮抗薬の世界の成長に絶えず貢献しています。さらに、世界中で心血管疾患の患者が増加していることから、主要企業は新しい治療薬を開発し、市場での地位を維持するために多額の投資を行っています。ヘルスケアのインフラ整備がカルシウム拮抗薬の需要を高めています。例えば、2022年2月、FDAはCMP PharmaのNorliqva経口溶液を承認しました。さらに、この内服液は高血圧の治療に役立ち、成人および6歳の小児の血圧を下げます。Norliqvaは150mL入りで、36ヶ月の使用期限があります。

目次

第1章 カルシウムチャネルブロッカー市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 カルシウムチャネルブロッカーの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 カルシウムチャネル遮断薬の産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 カルシウムチャネルブロッカー市場：COVID-19感染症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 カルシウムチャネルブロッカーの市場情勢

  • カルシウムチャネルブロッカー市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 カルシウムチャネルブロッカー市場-薬剤クラス別

  • 概要
    • 薬剤クラス別のセグメントシェア分析
    • ジヒドロピリジン
    • フェニルアルキルアミン
    • ベンゾチゼピン

第8章 カルシウムチャネルブロッカー市場- アプリケーション別

  • 概要
    • アプリケーション別のセグメントシェア分析
    • 狭心症
    • 高血圧
    • 肥大型心筋症
    • 不整脈
    • その他

第9章 カルシウムチャネルブロッカー市場- 流通チャネル別

  • 概要
    • 販売チャネル別のセグメントシェア分析
    • オンライン薬局
    • 病院薬局
    • 小売薬局

第10章 カルシウムチャネルブロッカー市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- カルシウムチャネルブロッカー業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Bayer
    • Sanofi
    • Wyeth-Ayerst
    • ClearSynth
    • AbMole Bioscience
    • Pfizer
    • Lupin Pharmaceuticals, Inc.
    • Searle
    • Knoll Pharmaceuticals
    • GlaxoSmithKline Plc.
    • Aventis
    • AstraZeneca
    • Novartis

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Calcium Channel Blockers Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Calcium Channel Blockers Market, by Drug Class2018-2030 (USD Million)
  • TABLE Calcium Channel Blockers Market: ApplicationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Calcium Channel Blockers Market, by Application2018-2030 (USD Million)
  • TABLE Calcium Channel Blockers Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Calcium Channel Blockers Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Calcium Channel Blockers Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Calcium Channel Blockers Market, by Region 2018-2030 (USD Million)
  • TABLE North America Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Calcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE EuropeCalcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Calcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Calcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Calcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE Calcium Channel Blockers Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Class segment market share analysis, 2022&2030
  • FIGURE Drug Class segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022&2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2022&2030
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Calcium Channel Blockers Market share and leading players, 2022
  • FIGURE Europe Calcium Channel Blockers Market share and leading players, 2022
  • FIGURE Asia Pacific Calcium Channel Blockers Market share and leading players, 2022
  • FIGURE Latin America Calcium Channel Blockers Market share and leading players, 2022
  • FIGURE Middle East and Africa Calcium Channel Blockers Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Calcium Channel Blockers Market share analysis by country, 2022
  • FIGURE Germany Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Calcium Channel Blockers Market share analysis by country, 2022
  • FIGURE India Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Calcium Channel Blockers Market share analysis by country, 2022
  • FIGURE Brazil Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Calcium Channel Blockers Market share analysis by country, 2022
  • FIGURE Saudi Arabia Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Calcium Channel Blockers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1601

REPORT HIGHLIGHT

Calcium Channel Blockers Market size was valued at USD 14,005.1 Million in 2022, expanding at a CAGR of 6.1% from 2023 to 2030.

Calcium channel blockers are known as medications that are utilized to maintain high blood pressure, arrhythmia, and chest pain. Additionally, they can be obtained through prescription and work by relaxing blood vessels and improving the heart's blood and oxygen supply. As a result, this helps to minimize the workload of the heart. Moreover, to treat high blood pressure and angina, it may be prescribed by itself or in conjunction with other medications.

Calcium Channel Blockers Market- Market Dynamics:

  • The increasing prevalence rate of cardiovascular diseases and rising assistance to people with anxiety disorders or bipolar disorder is projected to drive growth in the forecast period.
  • The changing lifestyle of people has resulted in the increasing prevalence rate of cardiovascular diseases is likely to fuel the calcium channel blocker market growth. As these diseases impact the heart or blood vessels and lower the risk of heart failure & stroke, calcium channel blockers are used. Additionally, the major causes associated with heart disease are hypertension, often referred to as elevated blood pressure. The effectiveness of calcium antagonists in curing this indication has been well documented. This in turn, the demand has been growing steadily for this market for improved management of cardiovascular diseases. However, side effects concerning calcium channel blockers including headache, constipation, and edema are expected to hinder the demand for calcium channel blocker market globally. Moreover, calcium channel blockers may be advantageous to a smaller group of persons who do not have heart issues. In line with this, some indications they may act as mood stabilizers and assist those people who suffer from anxiety disorders or bipolar disorder. The latter is specifically under investigation because some calcium channel blockers may be more secure to administer to pregnant women as compared to most traditional mood stabilizers or antipsychotics. Thus, such factors offer opportunity to increase the growth of the calcium channel blocker market.

Calcium Channel Blockers Market- Key Insights:

  • As per the analysis shared by our research analyst, the global calcium channel blocker market is estimated to grow annually at a CAGR of around 6.1% over the forecast period (2023-2030)
  • The calcium channel blocker industry is projected to grow at a significant rate due to the increasing prevalence rate of cardiovascular diseases
  • Based on drug class segmentation, dihydropyridine was predicted to show maximum market share in the year 2022
  • Based on application segmentation, hypertension was the leading type over the forecast period
  • On the basis of region, North America was the leading revenue generator in 2022

Calcium Channel Blockers Market- Segmentation Analysis:

  • The global calcium channel blockers market is segmented on the basis of drug class, application, distribution channel, and region.
  • The market is divided into three categories based on drug class: dihydropyridine, phenylalkylamine, and benzothizepine. The dihydropyridine segment is likely to possess the largest revenue share. The segment is anticipated due to the increasing research & development activities and expansion in the pharmaceutical industry. Moreover, the drug has great vascular selectivity and the capacity to control arterial pressure and vascular resistance, which is widely preferred in therapeutics. Dihydropyridine drugs include felodipine, amlodipine, nitrendipine, and nimodipine.
  • The market is divided into four categories based on application: angina, hypertension, hypertrophic cardiomyopathy, arrhythmia, and others. The hypertension segment is expected to hold the largest market share. The hypertension segment raises the risk of heart, brain, and renal problems. Based on this, the demand is likely to increase for drugs used to manage hypertension.
  • The market is divided into three categories based on distribution channels: online pharmacies, hospital pharmacies, and retail pharmacies. The retail pharmacies segment is accounted to dominate the market over the forecast period. The unhealthy lifestyle patterns have been resulting in increasing glowing obesity and cardiovascular diseases. As such drugs are prescribed on a regular basis to maintain the blood pressure. Additionally, rising cases of cardiovascular diseases such as congenital heart disease, heart failure, hypertension, and heart attacks are fueling the expansion of retail medicine owing to increase abundance and high consumption in the market.

Calcium Channel Blockers Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Calcium Channel Blockers Market- Competitive Landscape:

The presence of local and global companies makes the calcium channel blocker market moderately competitive. The major players are focusing on numerous growth strategies such as collaborations, product launches, and acquisitions, which are contributing constantly to the growth of the calcium channel blocker globally. Moreover, with the increasing cases of cardiovascular disease across the world, key players are investing amounts to develop new therapeutics and sustain themselves in the market. The improved healthcare infrastructure is raising the demand for the calcium channel blocker. For instance, in February 2022, FDA approved CMP Pharma's Norliqva oral solution. Additionally, the solution helps to treat hypertension, to lower blood pressure in adults & children 6 years of age. Norliqva comes in 150 mL bottles, which have 36-month dating

Recent Developments:

For instance, in May 2021, Milestone Pharmaceuticals, Inc. a biopharmaceutical company released positive topline safety and efficacy data from the Etripamil Phase 3 RAPID clinical trial. Additionally, the company's investigational calcium channel blocker in patients with paroxysmal supraventricular tachycardia (PSVT).

Key features of the study:

  • This proposed research study on calcium channel blockers market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the calcium channel blockers market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for calcium channel blockers market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the calcium channel blockers market.
  • Impact of COVID-19 on calcium channel blockers market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on calcium channel blockers market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the calcium channel blockers market, we have also included competitive landscape and key innovator analysis for the calcium channel blockers market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the calcium channel blockers market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global calcium channel blockers market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CALCIUM CHANNEL BLOCKERS MARKET KEY PLAYERS

  • Bayer
  • Sanofi
  • Wyeth-Ayerst
  • ClearSynth
  • AbMole Bioscience
  • Pfizer
  • Lupin Pharmaceuticals, Inc.
  • Searle
  • Knoll Pharmaceuticals
  • GlaxoSmithKline Plc.
  • Aventis
  • AstraZeneca
  • Novartis

GLOBALCALCIUM CHANNEL BLOCKERS MARKET, BY DRUG CLASS

  • Dihydropyridine
  • Phenylalkylamine
  • Benzothizepine

GLOBAL CALCIUM CHANNEL BLOCKERS MARKET, BY APPLICATION

  • Angina
  • Hypertension
  • Hypertrophic Cardiomyopathy
  • Arrhythmia
  • Others

GLOBAL CALCIUM CHANNEL BLOCKERS MARKET, BY DISTRIBUTION CHANNEL

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies

GLOBAL CALCIUM CHANNEL BLOCKERS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Calcium Channel Blockers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Calcium Channel Blockers Market Snippet by Drug Class
    • 2.1.2. Calcium Channel Blockers Market Snippet by Application
    • 2.1.3. Calcium Channel Blockers Market Snippet by Distribution Channel
    • 2.1.4. Calcium Channel Blockers Market Snippet by Country
    • 2.1.5. Calcium Channel Blockers Market Snippet by Region
  • 2.2. Competitive Insights

3. Calcium Channel Blockers Key Market Trends

  • 3.1. Calcium Channel Blockers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Calcium Channel Blockers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Calcium Channel Blockers Market Opportunities
  • 3.4. Calcium Channel Blockers Market Future Trends

4. Calcium Channel Blockers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Calcium Channel Blockers Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Calcium Channel Blockers Market Landscape

  • 6.1. Calcium Channel Blockers Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Calcium Channel Blockers Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022&2030 (%)
    • 7.1.2. Dihydropyridine
    • 7.1.3. Phenylalkylamine
    • 7.1.4. Benzothizepine

8. Calcium Channel Blockers Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Angina
    • 8.1.3. Hypertension
    • 8.1.4. Hypertrophic Cardiomyopathy
    • 8.1.5. Arrhythmia
    • 8.1.6. Others

9. Calcium Channel Blockers Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022&2030 (%)
    • 9.1.2. Online Pharmacies
    • 9.1.3. Hospital Pharmacies
    • 9.1.4. Retail Pharmacies

10. Calcium Channel Blockers Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Calcium Channel Blockers Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Calcium Channel Blockers Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Calcium Channel Blockers Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Calcium Channel Blockers Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Calcium Channel Blockers Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Calcium Channel Blockers Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Bayer
    • 11.2.2. Sanofi
    • 11.2.3. Wyeth-Ayerst
    • 11.2.4. ClearSynth
    • 11.2.5. AbMole Bioscience
    • 11.2.6. Pfizer
    • 11.2.7. Lupin Pharmaceuticals, Inc.
    • 11.2.8. Searle
    • 11.2.9. Knoll Pharmaceuticals
    • 11.2.10. GlaxoSmithKline Plc.
    • 11.2.11. Aventis
    • 11.2.12. AstraZeneca
    • 11.2.13. Novartis

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us